Patent Assignment
Reel/Frame 017115/0321
Merger
Recorded: 2006-02-03
Pages: 7
Assignor
EPIMMUNE INC.
Executed: 2005-08-15
Assignee
IDM PHARMA, INC.
5820 NANCY RIDGE DRIVE, SUITE 100, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(2)
Induction of Anti-Tumor Cytotoxic T Lymphocytes in Humans Using Synthetic Peptide Epitopes
Patent:
5,662,907 →
Application:
08/186,266 →
Hla Class I A2 Tumor Associated Antigen Peptides and Vaccine Compositions
Patent:
6,602,510 →
Application:
09/543,608 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 22, 1994
From: KUBO, RALPH T.; GREY, HOWARD M.; SETTE, ALESSANDRO; CELIS, ESTEBAN
To: CYTEL CORPORATION
Reel/Frame 007072/0244 →
Assignment of Assignor's Interest
Mar 2, 1998
From: CYTEL CORPORATION
To: EPIMMUNE, INC.
Reel/Frame 009167/0827 →
Assignment of Assignor's Interest
Oct 10, 2000
From: FIKES, JOHN; SETTE, ALESSANDRO; SIDNEY, JOHN; SOUTHWOOD, SCOTT
To: EPIMMUNE INC.
Reel/Frame 011193/0617 →
Assignment of Assignor's Interest
Aug 6, 2012
From: IDM PHARMA, INC.
To: BIOTECH SYNERGY, INC.
Reel/Frame 028727/0455 →
Assignment of Assignor's Interest
Jul 31, 2014
From: IDM PHARMA, INC.
To: BIOTECH SYNERGY, INC.
Reel/Frame 033453/0170 →
Assignment of Assignor's Interest
Jul 31, 2014
From: BIOTECH SYNERGY, INC.
To: OSE PHARMA INTERNATIONAL SA
Reel/Frame 033453/0211 →